Verdiva Bio
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $411M
Investors
- 7
About Verdiva Bio
Based in London, UK, and founded in 2024, Verdiva Bio Limited operates as developer of biopharmaceuticals focused on therapies for obesity and cardiometabolic disorders. The company’s flagship product, VRB-101, is an oral GLP-1 receptor agonist designed for once-weekly dosing, which has shown efficacy in clinical trials. Complementing this, Verdiva Bio is advancing several other products, including VRB-103, a dual amylin and calcitonin receptor agonist in preclinical development, which will serve as both a monotherapy and in combination with VRB-101. This portfolio addresses significant unmet medical needs and targets the end users consisting of patients suffering from obesity and cardiometabolic disorders.
Who invested in Verdiva Bio
7 investors across 1 round
See all investors in Verdiva Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 10, 2024
Amount
$411M
Investors
Questions about Verdiva Bio
Who invested in Verdiva Bio?
Verdiva Bio has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Verdiva Bio raised?
Verdiva Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Verdiva Bio last raise money?
Verdiva Bio's most recent round on record is a Series A, in Dec 2024.
What does Verdiva Bio do?
Based in London, UK, and founded in 2024, Verdiva Bio Limited operates as developer of biopharmaceuticals focused on therapies for obesity and cardiometabolic disorders.
Where is Verdiva Bio headquartered?
Verdiva Bio is headquartered in London, UK.
Which VCs invest in companies like Verdiva Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Verdiva Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Verdiva Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.